Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rna Diagnostics
Toronto, Ontario, Canadarnadiagnostics.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
Rna Diagnostics has developed the VERIDAPT DX predictive biomarker platform and the RNA Disruption Assay to provide early actionable insights into the effectiveness of neoadjuvant cancer therapies. In Phase I of their BREVITY clinical trial, their technology demonstrated high negative predictive value (>93%) in predicting therapy efficacy during early treatment. Phase II clinical validation trials are ongoing internationally at over forty centers. The technology aims to optimize patient outcomes by identifying non-responsive tumors early and enabling timely changes to treatment regimens.
- Therapeutic areas
- Oncology
- Modalities
- Diagnostic assay (RNA Disruption Assay)Biomarker platform (VERIDAPT DX)RNA-based diagnostics
- Industry
- Molecular Diagnostics
02
Partnerships
Global physiciansOver 40 breast cancer centers (Europe, North America)
Beyond the preview
Go deeper on Rna Diagnostics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Rna Diagnostics.